GE to buy cell-culture, gene-modulation units from Thermo Fisher Scientific
MLex Summary: GE Healthcare, the medical technologies and services division of NYSE-listed General Electric, has agreed to acquire NYSE-listed serving science company Thermo Fisher Scientific's cell culture media and sera, and gene modulation and magnetic beads...To view the full article, register now.
Already a subscriber? Click here to view full article